STOCK TITAN

embecta to Report Fiscal Fourth Quarter and Full Year 2026 Financial Results

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
earnings date

Embecta (Nasdaq: EMBC) will hold its fiscal fourth-quarter and full-year 2026 earnings call on November 24, 2026. The call starts at 8:00 a.m. ET and will include an operational update, preliminary fiscal 2027 financial guidance and a question-and-answer session. The webcast replay will be available starting at 11:00 a.m. ET that day and remain archived for one year.

Loading...
Loading translation...

Key Figures

Conference call: November 24, 2026, 8:00 a.m. ET
Conference call
November 24, 2026, 8:00 a.m. ET
FY26 fourth-quarter and full-year results; preliminary FY27 guidance

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

PARSIPPANY, N.J., Nov. 20, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal fourth quarter and full year 2026 financial results, provide an operational update, including preliminary fiscal year 2027 financial guidance, and host a question and answer session at 8:00 a.m. Eastern Time (ET) on Tuesday, November 24, 2026.

Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company's website at investors.embecta.com.

A webcast replay of the call will be available beginning at 11:00 a.m. ET on November 24, 2026, via the embecta investor relations website and archived on the website for one year.

About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,500 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.

Contacts:  
  
Media Investors 
Christian Glazar Patricia Gonzalez
Sr. Director, Corporate Communications VP, Corporate FP&A and Investor Relations
908-821-6922 862-341-2809
Contact Media Relations Contact IR

Keep reading